133 related articles for article (PubMed ID: 29960237)
1. Chemometrics-assisted study of the interconversion between the crystalline forms of nimodipine.
Calvo NL; Balzaretti NM; Antonio M; Kaufman TS; Maggio RM
J Pharm Biomed Anal; 2018 Sep; 158():461-470. PubMed ID: 29960237
[TBL] [Abstract][Full Text] [Related]
2. A dynamic thermal ATR-FTIR/chemometric approach to the analysis of polymorphic interconversions. Cimetidine as a model drug.
Calvo NL; Maggio RM; Kaufman TS
J Pharm Biomed Anal; 2014 Apr; 92():90-7. PubMed ID: 24509287
[TBL] [Abstract][Full Text] [Related]
3. Assessing the impact of nimodipine devitrification in the ternary cosolvent system through quality by design approach.
Rahman Z; Siddiqui A; Khan MA
Int J Pharm; 2013 Oct; 455(1-2):113-23. PubMed ID: 23911342
[TBL] [Abstract][Full Text] [Related]
4. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
[TBL] [Abstract][Full Text] [Related]
5. Chemometric evaluation of near infrared, fourier transform infrared, and Raman spectroscopic models for the prediction of nimodipine polymorphs.
Siddiqui A; Rahman Z; Sayeed VA; Khan MA
J Pharm Sci; 2013 Nov; 102(11):4024-35. PubMed ID: 23963767
[TBL] [Abstract][Full Text] [Related]
6. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
[TBL] [Abstract][Full Text] [Related]
7. Physicochemical characterization of nimodipine-polyethylene glycol solid dispersion systems.
Barmpalexis P; Kachrimanis K; Georgarakis E
Drug Dev Ind Pharm; 2014 Jul; 40(7):886-95. PubMed ID: 23611475
[TBL] [Abstract][Full Text] [Related]
8. Stabilization of solid dispersions of nimodipine and polyethylene glycol 2000.
Urbanetz NA
Eur J Pharm Sci; 2006 May; 28(1-2):67-76. PubMed ID: 16472995
[TBL] [Abstract][Full Text] [Related]
9. Biomimetic synthesis and evaluation of histidine-derivative templated chiral mesoporous silica for improved oral delivery of the poorly water-soluble drug, nimodipine.
Li H; Li H; Wei C; Ke J; Li J; Xu L; Liu H; YangYang ; Li S; Yang M
Eur J Pharm Sci; 2018 May; 117():321-330. PubMed ID: 29530545
[TBL] [Abstract][Full Text] [Related]
10. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
Yi T; Wan J; Xu H; Yang X
Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
[TBL] [Abstract][Full Text] [Related]
11. Mebendazole crystal forms in tablet formulations. An ATR-FTIR/chemometrics approach to polymorph assignment.
Calvo NL; Kaufman TS; Maggio RM
J Pharm Biomed Anal; 2016 Apr; 122():157-65. PubMed ID: 26874854
[TBL] [Abstract][Full Text] [Related]
12. At-line green synthesis monitoring of new pharmaceutical co-crystals lamivudine:theophylline polymorph I and II, quantification of polymorph I among its APIs using FT-IR spectroscopy and MCR-ALS.
Mazivila SJ; Castro RAE; Leitão JMM; Esteves da Silva JCG
J Pharm Biomed Anal; 2019 May; 169():235-244. PubMed ID: 30877935
[TBL] [Abstract][Full Text] [Related]
13. Phase transformations of amlodipine besylate solid forms.
Koradia V; de Lemos AF; Allesø M; de Diego HL; Ringkjøbing-Elema M; Müllertz A; Rantanen J
J Pharm Sci; 2011 Jul; 100(7):2896-910. PubMed ID: 21344410
[TBL] [Abstract][Full Text] [Related]
14. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method.
Zajc N; Obreza A; Bele M; Srcic S
Int J Pharm; 2005 Mar; 291(1-2):51-8. PubMed ID: 15707731
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Phase Separation Propensity for Amorphous Spray Dried Dispersions.
McNamara D; Yin S; Pan D; Crull G; Timmins P; Vig B
Mol Pharm; 2017 Feb; 14(2):377-385. PubMed ID: 28068097
[TBL] [Abstract][Full Text] [Related]
16. Physical-chemical characterization and polymorphism determination of two nimodipine samples deriving from distinct laboratories.
Cardoso TM; Rodrigues PO; Stulzer HK; Segatto Silva MA; do Rosário Matos J
Drug Dev Ind Pharm; 2005 Aug; 31(7):631-7. PubMed ID: 16207610
[TBL] [Abstract][Full Text] [Related]
17. Determination of the main solid-state form of albendazole in bulk drug, employing Raman spectroscopy coupled to multivariate analysis.
Calvo NL; Arias JM; Altabef AB; Maggio RM; Kaufman TS
J Pharm Biomed Anal; 2016 Sep; 129():190-197. PubMed ID: 27429368
[TBL] [Abstract][Full Text] [Related]
18. In vitro dissolution enhancement of micronized l-nimodipine by antisolvent re-crystallization from its crystal form H.
Zu Y; Li N; Zhao X; Li Y; Ge Y; Wang W; Wang K; Liu Y
Int J Pharm; 2014 Apr; 464(1-2):1-9. PubMed ID: 24456674
[TBL] [Abstract][Full Text] [Related]
19. Application of multivariate curve resolution alternating least squares (MCR-ALS) to the quantitative analysis of pharmaceutical and agricultural samples.
Azzouz T; Tauler R
Talanta; 2008 Feb; 74(5):1201-10. PubMed ID: 18371770
[TBL] [Abstract][Full Text] [Related]
20. Near-infrared and fourier transform infrared chemometric methods for the quantification of crystalline tacrolimus from sustained-release amorphous solid dispersion.
Rahman Z; Siddiqui A; Bykadi S; Khan MA
J Pharm Sci; 2014 Aug; 103(8):2376-85. PubMed ID: 24931728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
